×
About 36,658 results

ALLMedicine™ Mild Cognitive Impairment Center

Research & Reviews  17,485 results

Changes in local brain function in mild cognitive impairment due to semantic dementia.
https://doi.org/10.1111/cns.13621
CNS Neuroscience & Therapeutics; Cui L, Chen K et. al.

Mar 2nd, 2021 - Mild cognitive impairment due to semantic dementia represents the preclinical stage, involving cognitive decline dominated by semantic impairment below the semantic dementia standard. Therefore, studying mild cognitive impairment due to semantic d...

An elaborative NMR based plasma metabolomics study revealed metabolic derangements in p...
https://doi.org/10.1007/s11011-021-00700-z 10.1016/S1474-4422(11)70077-1 10.1111/jnc.12094 10.3390/ijms21082676 10.1093/jn/136.1.295S 10.1093/nar/gky310 10.1016/j.jchromb.2016.02.007 10.1016/j.neurobiolaging.2016.03.005 10.1016/j.jalz.2014.07.156 10.3390/pr7080488 10.1016/j.spen.2008.05.007 10.1111/nyas.12138 10.1016/j.jpba.2015.07.007 10.1007/s00216-014-8102-3 10.1002/elps.201400196 10.1016/j.talanta.2014.07.075 10.1016/j.jpba.2014.05.023 10.1016/j.jpba.2014.10.010 10.1016/j.jpba.2014.10.010 10.1007/s11306-015-0773-z 10.1016/j.jpba.2015.01.025 10.2174/1567205013666160129095138 10.1371/journal.pone.0119452 10.1007/s11306-013-0516-y 10.2174/1568026619666181120141603 10.1038/srep35309 10.1186/s12944-016-0320-6 10.1021/pr300666p 10.1016/j.ibmb.2004.10.002 10.1602/neurorx.1.2.226 10.1021/pr800439b 10.1038/tp.2013.18 10.1148/radiology.219.1.r01ap14101 10.3233/JAD-132165 10.1016/j.jpba.2019.113080 10.1016/j.jchromb.2015.01.016 10.1039/C5RA19349D 10.1002/acn3.726 10.3389/fpsyt.2018.00561 10.1038/nm.3466 10.1038/nm.3466 10.1073/pnas.0505513102 10.1001/archneur.58.12.1985 10.2337/dc19-0120 10.1056/NEJMoa013128 10.1016/j.neuint.2010.04.001 10.1016/S0140-6736(15)01124-1 10.1001/archneurol.2011.69 10.1586/14737159.6.5.717 10.3233/JAD-2012-112231 10.1155/2009/915041 10.3748/wjg.v19.i43.7620 10.1371/journal.pone.0063644 10.1002/cem.695 10.1016/j.jalz.2017.11.012 10.1016/j.nut.2009.11.009 10.1016/j.neuint.2006.10.007 10.1021/pr5000895 10.1016/j.neuroscience.2016.06.049 10.1212/WNL.0b013e3182190d09
Metabolic Brain Disease; Kumar U, Kumar A et. al.

Mar 2nd, 2021 - Mild cognitive impairment (MCI) is transition phase between cognitive decline and dementia. The current study aims to investigate altered metabolic pattern in plasma of MCI for potential biomarkers. MCI (N = 50) and healthy controls (HC, N = 50) a...

Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (M...
https://doi.org/10.1002/alz.12219
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Alden EC, Pudumjee SB et. al.

Mar 2nd, 2021 - This study evaluated the diagnostic accuracy of the Cogstate Brief Battery (CBB) for mild cognitive impairment (MCI) and prodromal Alzheimer's disease (AD) in a population-based sample. Participants included adults ages 50+ classified as cognitive...

Diabetic patients are deficient in intentional visuospatial learning and show different...
https://doi.org/10.1080/13803395.2020.1853065
Journal of Clinical and Experimental Neuropsychology; Mejía-Rodríguez O, Zavala-Calderón E et. al.

Mar 1st, 2021 - Introduction: We hypothesized that diabetic patients without mild cognitive impairment would present deficiencies in visuospatial incidental/intentional memory processing and alterations in the underlying EEG alpha, theta and gamma patterns.Method...

Distinct Profile Differences in Subjective Cognitive Decline in the General Public are ...
https://doi.org/10.3233/JAD-200882
Journal of Alzheimer's Disease : JAD; Jenkins A, Tree J et. al.

Mar 1st, 2021 - Subjective cognitive decline (SCD) is increasingly recognized in both the clinical and research arenas as a risk factor for mild cognitive impairment (MCI) and dementia. Although SCD is etiologically heterogeneous and potentially treatable, in com...

see more →

Guidelines  25 results

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force R...
https://doi.org/10.1001/jama.2020.0435
JAMA , Owens DK et. al.

Feb 25th, 2020 - Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individual...

Intensive blood pressure management may preserve brain health
https://www.mdlinx.com/neurology/top-medical-news/article/2019/08/14/7575730

Aug 13th, 2019 - Numerous large, cohort studies have linked midlife hypertension to mild cognitive impairment and dementia later on. Some of these studies found a higher risk of lesions in the brain's white matter in older age among people with high blood pressure...

Longitudinal study of hearing loss and subjective cognitive function decline in men
https://www.alzheimersanddementia.com/article/S1552-5260(18)33606-9/fulltext
Curhan,S.,et al

Jan 28th, 2019 - Introduction: We examined the relation between self-reported hearing loss, hearing aid use, and risk of subjective cognitive function (SCF) decline. Methods: We conducted an 8-year (2008–2016) longitudinal study of 10,107 men aged ≥62 years who re...

Treatment of dementia and mild cognitive impairment with or without cerebrovascular dis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488894
CNS Neuroscience & Therapeutics; Kandiah N, Ong PA et. al.

Jan 16th, 2019 - The Ginkgo biloba special extract, EGb 761® has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer's disease (AD). To guide clinical practice in the Asian region, the Asian Clinical Expert Group on Neurocognitive ...

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011905.pub2/full
The Cochrane Database of Systematic Reviews; McCleery,J.,et al

Oct 31st, 2018 - Background Vitamins and minerals have many functions in the nervous system which are important for brain health. It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and del...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  18,149 results

Changes in local brain function in mild cognitive impairment due to semantic dementia.
https://doi.org/10.1111/cns.13621
CNS Neuroscience & Therapeutics; Cui L, Chen K et. al.

Mar 2nd, 2021 - Mild cognitive impairment due to semantic dementia represents the preclinical stage, involving cognitive decline dominated by semantic impairment below the semantic dementia standard. Therefore, studying mild cognitive impairment due to semantic d...

An elaborative NMR based plasma metabolomics study revealed metabolic derangements in p...
https://doi.org/10.1007/s11011-021-00700-z 10.1016/S1474-4422(11)70077-1 10.1111/jnc.12094 10.3390/ijms21082676 10.1093/jn/136.1.295S 10.1093/nar/gky310 10.1016/j.jchromb.2016.02.007 10.1016/j.neurobiolaging.2016.03.005 10.1016/j.jalz.2014.07.156 10.3390/pr7080488 10.1016/j.spen.2008.05.007 10.1111/nyas.12138 10.1016/j.jpba.2015.07.007 10.1007/s00216-014-8102-3 10.1002/elps.201400196 10.1016/j.talanta.2014.07.075 10.1016/j.jpba.2014.05.023 10.1016/j.jpba.2014.10.010 10.1016/j.jpba.2014.10.010 10.1007/s11306-015-0773-z 10.1016/j.jpba.2015.01.025 10.2174/1567205013666160129095138 10.1371/journal.pone.0119452 10.1007/s11306-013-0516-y 10.2174/1568026619666181120141603 10.1038/srep35309 10.1186/s12944-016-0320-6 10.1021/pr300666p 10.1016/j.ibmb.2004.10.002 10.1602/neurorx.1.2.226 10.1021/pr800439b 10.1038/tp.2013.18 10.1148/radiology.219.1.r01ap14101 10.3233/JAD-132165 10.1016/j.jpba.2019.113080 10.1016/j.jchromb.2015.01.016 10.1039/C5RA19349D 10.1002/acn3.726 10.3389/fpsyt.2018.00561 10.1038/nm.3466 10.1038/nm.3466 10.1073/pnas.0505513102 10.1001/archneur.58.12.1985 10.2337/dc19-0120 10.1056/NEJMoa013128 10.1016/j.neuint.2010.04.001 10.1016/S0140-6736(15)01124-1 10.1001/archneurol.2011.69 10.1586/14737159.6.5.717 10.3233/JAD-2012-112231 10.1155/2009/915041 10.3748/wjg.v19.i43.7620 10.1371/journal.pone.0063644 10.1002/cem.695 10.1016/j.jalz.2017.11.012 10.1016/j.nut.2009.11.009 10.1016/j.neuint.2006.10.007 10.1021/pr5000895 10.1016/j.neuroscience.2016.06.049 10.1212/WNL.0b013e3182190d09
Metabolic Brain Disease; Kumar U, Kumar A et. al.

Mar 2nd, 2021 - Mild cognitive impairment (MCI) is transition phase between cognitive decline and dementia. The current study aims to investigate altered metabolic pattern in plasma of MCI for potential biomarkers. MCI (N = 50) and healthy controls (HC, N = 50) a...

Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (M...
https://doi.org/10.1002/alz.12219
Alzheimer's & Dementia : the Journal of the Alzheimer's A... Alden EC, Pudumjee SB et. al.

Mar 2nd, 2021 - This study evaluated the diagnostic accuracy of the Cogstate Brief Battery (CBB) for mild cognitive impairment (MCI) and prodromal Alzheimer's disease (AD) in a population-based sample. Participants included adults ages 50+ classified as cognitive...

Hearing Aid Use Independently Associated with Reduced Dementia Risk
https://www.medscape.com/viewarticle/946679

Mar 1st, 2021 - Takeaway Hearing aid (HA) use is independently associated with a lower risk of incident dementia in individuals with mild cognitive impairment (MCI). Slower cognitive decline is seen in users than non-users of HA with MCI. Why this matters The cau...

Diabetic patients are deficient in intentional visuospatial learning and show different...
https://doi.org/10.1080/13803395.2020.1853065
Journal of Clinical and Experimental Neuropsychology; Mejía-Rodríguez O, Zavala-Calderón E et. al.

Mar 1st, 2021 - Introduction: We hypothesized that diabetic patients without mild cognitive impairment would present deficiencies in visuospatial incidental/intentional memory processing and alterations in the underlying EEG alpha, theta and gamma patterns.Method...

see more →

News  983 results

Hearing Aid Use Independently Associated with Reduced Dementia Risk
https://www.medscape.com/viewarticle/946679

Mar 1st, 2021 - Takeaway Hearing aid (HA) use is independently associated with a lower risk of incident dementia in individuals with mild cognitive impairment (MCI). Slower cognitive decline is seen in users than non-users of HA with MCI. Why this matters The cau...

New and Improved Way to Predict MCI on the Horizon?
https://www.medscape.com/viewarticle/945615

Feb 9th, 2021 - Researchers have uncovered what they believe is a unique brainwave pattern that predicts the risk for mild cognitive impairment (MCI), a frequent precursor to dementia. The study results suggest a memory test that uses electroencephalography (EEG)...

Obesity May Exacerbate the Effects of Alzheimer’s Disease
https://www.medscape.com/viewarticle/945090

Feb 1st, 2021 - Obesity can contribute towards neural tissue vulnerability in cognitively healthy individuals and those with mild cognitive impairment, according to new research involving University of Sheffield. The study findings also suggests maintaining a hea...

More Evidence Anticholinergics Increase MCI Risk
https://www.medscape.com/viewarticle/939054

Oct 12th, 2020 - Common anticholinergics, both over-the-counter and prescription, are tied to a significantly increased risk for mild cognitive impairment (MCI) and cognitive decline in elderly individuals with otherwise normal cognitive function, new research con...

More Evidence Links Gum Disease and Dementia Risk
https://www.medscape.com/viewarticle/935948

Aug 18th, 2020 - Periodontal disease is associated with later development of mild cognitive impairment (MCI) or dementia, especially in those with severe gum inflammation and edentulism (tooth loss), new research suggests. Over a 20-year period, investigators pros...

see more →

Patient Education  15 results see all →